Multi-epitope tick vaccines: From computational design to field deployment, immunoinformatics approaches, validation...

Area of Science:

• Veterinary Entomology
• Vaccine Design
• Bioinformatics

Background:

• Ticks are significant vectors of diseases in humans and animals, necessitating improved control strategies.
• Conventional vaccines like Bm86 offer limited protection due to antigenic variability and strain-specific responses.
• Advances in immunoinformatics enable the rational design of multi-epitope vaccines (MEVs) targeting key tick proteins.

Purpose of the Study:

• To review current approaches for MEV design in anti-tick vaccines.
• To discuss bioinformatic tools and experimental validation methods in MEV development.
• To identify limitations and future directions for next-generation anti-tick vaccines.

Main Methods:

• Antigen selection and epitope prediction using immunoinformatics.
• In silico safety assessment (antigenicity, allergenicity, toxicity).
• Structural modeling, molecular docking, molecular dynamics, and experimental validation (in vitro/in vivo).

Main Results:

• Immunoinformatics facilitates rational design of MEVs by integrating B-cell and T-cell epitopes.
• Computational tools aid in epitope selection, construct stability, and safety assessment.
• Experimental validation is crucial to confirm immunogenicity and protective efficacy of in silico-designed vaccines.

Conclusions:

• Integrated computational and experimental approaches provide a framework for next-generation anti-tick vaccines.
• Overcoming limitations like tick biological redundancy and genetic variability is key.
• MEVs hold potential to complement existing control measures for sustainable vector management under a One Health perspective.